Sinocelltech (China) Today
| 688520 Stock | 39.00 0.62 1.62% |
Performance7 of 100
| Odds Of DistressLess than 25
|
Sinocelltech is trading at 39.00 as of the 30th of November 2024, a 1.62 percent increase since the beginning of the trading day. The stock's open price was 38.38. Sinocelltech has about a 25 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Sinocelltech Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Sinocelltech is entity of China. It is traded as Stock on SHG exchange. The company has 445.34 M outstanding shares. More on Sinocelltech Group
Moving together with Sinocelltech Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Sinocelltech Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sinocelltech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sinocelltech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman GM | Liangzhi Xie | ||||
| Thematic Idea | IT (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, IT, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors) | ||||
Sinocelltech's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Sinocelltech's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsSinocelltech can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sinocelltech's financial leverage. It provides some insight into what part of Sinocelltech's total assets is financed by creditors.
| |||||
Sinocelltech Group (688520) is traded on Shanghai Stock Exchange in China and employs 2,313 people. Sinocelltech is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sinocelltech's market, we take the total number of its shares issued and multiply it by Sinocelltech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sinocelltech Group operates under Biotechnology sector and is part of Health Care industry. The entity has 445.34 M outstanding shares.
Sinocelltech generates negative cash flow from operations
Check Sinocelltech Probability Of Bankruptcy
Ownership AllocationSinocelltech Group shows a total of 445.34 Million outstanding shares. Sinocelltech Group has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.23 % of Sinocelltech outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sinocelltech Ownership Details
Sinocelltech Group Risk Profiles
Although Sinocelltech's alpha and beta are two of the key measurements used to evaluate Sinocelltech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.81 | |||
| Semi Deviation | 3.57 | |||
| Standard Deviation | 4.06 | |||
| Variance | 16.46 |
Sinocelltech Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sinocelltech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Other Information on Investing in Sinocelltech Stock
Sinocelltech financial ratios help investors to determine whether Sinocelltech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sinocelltech with respect to the benefits of owning Sinocelltech security.